» Articles » PMID: 39696713

Systematic Review and Meta-analysis of the Association of Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio with Periodontitis

Overview
Journal Eur J Med Res
Publisher Biomed Central
Specialty General Medicine
Date 2024 Dec 19
PMID 39696713
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Recent evidence suggests the relationship between periodontitis and systemic inflammation, which complete blood count can assess (CBC)-derived biomarkers such as neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR). We conducted this meta-analysis to evaluate the levels of NLR and PLR of patients with periodontitis compared to those of healthy controls.  METHODS: Web of Science, PubMed, ProQuest, Scopus, and Open Grey were searched for studies published before October 20, 2024, without any limitation on date and language; then, using the random-effects model, we reported a standardized mean difference (SMD) with a 95% confidence interval (CI). In order to assess the quality of publications, we used the Newcastle-Ottawa scale (NOS). Our study was registered in PROSPERO (CRD42023475214).

Results: Overall, 11 articles were included in the analysis. We found that patients with periodontitis had elevated levels of NLR compared to healthy controls (SMD = 0.30, 95% CI 0.08-0.52, p = 0.007) In the subgroup analysis according to race, patients with periodontitis had elevated levels of NLR compared to healthy controls in among East Asian patients (SMD = 0.35, 95% CI 0.15-0.55, p = 0.001), but not among Turkish (SMD = 0.15, 95% CI - 0.30-0.61, p = 0.50) and Indian (SMD = 0.38, 95% CI - 0.17-0.94, p = 0.18) patients. In addition, PLR level was not different among patients with periodontitis and healthy controls (SMD = 0.06, 95% CI - 0.71-0.83, p = 0.87).

Conclusions: The findings of our investigation, which indicate higher NLR levels in periodontitis patients, show that immune dysregulation plays a role in the etiology of the disease.

References
1.
Ahmad N, Ahmad F, Bedi S, Sharma S, Umar S, Ansari M . A novel Nanoformulation Development of Eugenol and their treatment in inflammation and periodontitis. Saudi Pharm J. 2019; 27(6):778-790. PMC: 6733787. DOI: 10.1016/j.jsps.2019.04.014. View

2.
Kinane D, Stathopoulou P, Papapanou P . Periodontal diseases. Nat Rev Dis Primers. 2017; 3:17038. DOI: 10.1038/nrdp.2017.38. View

3.
Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View

4.
Hajishengallis G . New developments in neutrophil biology and periodontitis. Periodontol 2000. 2019; 82(1):78-92. DOI: 10.1111/prd.12313. View

5.
Cheng R, Wu Z, Li M, Shao M, Hu T . Interleukin-1β is a potential therapeutic target for periodontitis: a narrative review. Int J Oral Sci. 2020; 12(1):2. PMC: 6949296. DOI: 10.1038/s41368-019-0068-8. View